Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 102Colorectal Cancer Screening and DetectionGlobal Cancer Incidence and ScreeningHealth Promotion and Cardiovascular Prevention

The DOI matches its Crossref record; 59 of the 62 references it cites were found in a registry or an index.

Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey

Open access

Abstract

In the past two decades, an extensive rollout of colorectal cancer (CRC) screening programmes has been initiated in European countries with a large heterogeneity of screening offers. Using data from a population-based cross-sectional survey conducted between 2013 and 2016 in all European Union countries, we analysed the utilisation of faecal tests and colonoscopy among people aged 50–74 years and the factors associated with uptake by type of screening offer. We observed the highest utilisation of either test for countries with fully rolled out organised programmes with faecal tests (ranging from 29.7% in Croatia to 66.7% in the UK) and countries offering both faecal tests and colonoscopy (from 22.7% in Greece to 70.9% in Germany). Utilisation was very low for countries with no programme (from 6.3% in Romania to 30.5% in Norway). Younger age (50–54 years), longer time since last consultation with a doctor and a lifestyle score associated with increased CRC risk were significantly associated with lower test use, a pattern observed across all types of screening offers. Our results suggest that more countries should implement organised programmes with faecal immunochemical tests, in combination with alternative endoscopy offers where resources allow. Furthermore, there is a large potential for increasing screening use in Europe by better reaching the younger eligible individuals, those who have not been to the doctor recently and those at increased risk for CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers12061409

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Prevalence estimates of faecal test use within the previous 2 years among the general population aged 50–74 years in all EU countries, Iceland, Norway and the UK, by type of screening offer (data: EHIS, 2013-2016).
Figure 1 Prevalence estimates of faecal test use within the previous 2 years among the general population aged 50–74 years in all EU countries, Iceland, Norway and the UK, by type of screening offer (data: EHIS, 2013-2016).CC BY · PubMed Central
Figure 2 Prevalence estimates of colonoscopy use within the previous 10 years among the general population aged 50–74 years in all EU countries, Iceland, Norway and the UK, by type of screening offer (data: EHIS, 2013–2016). For Sweden, colonoscopy use was determined within the past 5 years.
Figure 2 Prevalence estimates of colonoscopy use within the previous 10 years among the general population aged 50–74 years in all EU countries, Iceland, Norway and the UK, by type of screening offer (data: EHIS, 2013–2016). For Sweden, colonoscopy use was determined within the past 5 years.CC BY · PubMed Central
Figure 3 Prevalence estimates of faecal test use within the previous 2 years or colonoscopy use within the previous 10 years among the general population aged 50–74 years in all EU countries, Iceland, Norway and the UK, by type of screening offer (data: EHIS, 2013–2016). For Sweden, colonoscopy use was determined within the past 5 years.
Figure 3 Prevalence estimates of faecal test use within the previous 2 years or colonoscopy use within the previous 10 years among the general population aged 50–74 years in all EU countries, Iceland, Norway and the UK, by type of screening offer (data: EHIS, 2013–2016). For Sweden, colonoscopy use was determined within the past 5 years.CC BY · PubMed Central
Figure 4 Flowchart of respondents included in, and excluded from, the analyses due to a lack of data on the outcome measures or proxy interviews.
Figure 4 Flowchart of respondents included in, and excluded from, the analyses due to a lack of data on the outcome measures or proxy interviews.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 62 references

Research works printed but not linked: 1

  1. 2012, O cancro colorretal e o rastreio: Conhecimentos e atitudes dos portuenses [Colorectal cancer and screening: Portuenses’ knowledge and attitudes], GE Port. J. Gastroenterol., 19, 118

Cited by

See all 102

Metadata

Authors
Cardoso, R., Guo, F., Heisser, T., Hoffmeister, M., & Brenner, H.
Affiliations
German Cancer Research Center (DE)
Corresponding author
Cardoso, Rafael
Venue
Cancers
Publisher
MDPI AG
Published
2020-05-29
Volume
12
Issue
6
Pages
1409
ISSN
2072-6694 (ISSN-L)
OpenAlex
W3032515977
Cited by
102
References
62
Citations by year
2026: 12 · 2025: 20 · 2024: 15 · 2023: 23 · 2022: 15 · 2021: 12 · 2020: 4
FWCI
4.88
Type
journal article
Language
en
Open access
Locations
  • Cancers (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Deutsche Krebshilfe (70112095)
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Keywords
colorectal cancer screening, fecal immunochemical test, colonoscopy, screening uptake, organized screening programs, European Health Interview Survey, age at screening, lifestyle risk factors, colorectal cancer risk, EU member states

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey. https://app.cochat.ai/papers/10.3390/cancers12061409
The paper
Cardoso, R., Guo, F., Heisser, T., Hoffmeister, M., & Brenner, H. (2020). Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey. Cancers. https://doi.org/10.3390/cancers12061409

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.